From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Payment Disclosure
Charles B. Nemeroff
- $111
- paid by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson »
- Location: Miami, Fla.
- Payment for: Business Meals for Business Discussion
- Payment for: Business Meals for Business Discussion
- Reported: Jan. to Dec. 2011 Janssen Pharmaceuticals
- Search for Charles B. Nemeroff in Prescriber Checkup, our database of prescribing patterns within Medicare's drug program.
Notable drugs produced by Janssen Pharmaceuticals include:
- Risperdal Consta (antipsychotic for schizophrenia and Bipolar I Disorder)
- Invega (schizophrenia & schizoaffective disorder)
- Invega Sustenna (schizophrenia)
- Nucynta (painkiller)
- Nucynta ER (painkiller)
- Ortho Evra (contraceptive)
- Ortho Tri-Cyclen LO (contraceptive)
- Xarelto (reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, deep vein thrombosis, pulmonary embolism)
Important notes
The reports include both the name of the health provider who performed the service and, when reported, the entity paid. They may be different.
Source: Johnson & Johnson. ProPublica last downloaded this record on Jan. 9, 2013.
I think this is my doctor — what should I do?
If your provider is listed, it’s because a drug company reported paying him or her for promotional activities, meals, travel, educational items, consulting or research. Such payments are legal, but research has shown that drug-company marketing can influence what a doctor prescribes. How you can use this data »
Get personalized questions to ask your doctor
Print out this record, along with questions and tips for talking with your physician about drug company payments.
Get checklistWhat Companies Disclose
See which services Johnson & Johnson and other pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.